Menarini Hellas S.A.

menarini_new_eksw

Foundation Date:
1989

Managing Director:
Georgios Ch. Sykianakis

Number of Employees (31/12/2009):
178

Turnover (31/12/2009):
46.380.909,33€

HISTORY

Menarini International Pharmaceutical Group started operations in Greece in 1989 by acquiring 70% of DAMVERGIS S.A., a long-established pharmaceutical company with presence in Greece since 1935.

In 1996 Menarini International acquires 100% of Damvergis S.A. capital stock, renaming the Greek division in Menarini Hellas S.A.

From 1989 until today the company, launched in the pharmaceutical market many original pharmaceuticals products in the category of the cardiovascular system but also in other major therapeutic categories.

The successful performance of the company over the last 20 years established the Menarini Hellas as a new and dynamic company in the field of pharmaceutical market. Menarini is already ranked among the 15 largest pharmaceutical companies in Greece.

Today, the employees of MENARINI HELLAS are 178, 80% men and 20% women, averaging 35 years of age.

MISSION

To actively contribute in the improvement of human health, by offering high quality, innovative drugs.

VISION

To establish Menarini Hellas as a reliable and efficient company in promoting high quality pharmaceutical products, showing both high sensitivity and social responsibility. Additionally, to become an ideal collaboration partner for all the major international pharmaceutical companies and research organizations.

PHARMACEUTICAL COMPOUNDS PER DISEASE

DISEASE ACTIVE SUBSTANCE PRODUCT NAME
HYPERTENSION OLMESARTAN MEDOMOXIL OLARTAN
OLMESARTAN MEDOMOXIL & HYDROCHLOROTHIAZIDE OLARTAN PLUS
OLMESARTAN MEDOMOXIL & AMLODIPINE ORIZAL
ZOFENOPRIL ZOFEPRIL
ZOFENOPRIL & HYDROCHLOROTHIAZIDE ZOFEPRIL PLUS
CAPTOPRIL & HYDROCHLOROTHIAZIDE URESAN
NEBIVOLOL & HYDROCHLOROTHIAZIDE LOBIVON PLUS
HYPERTENSION AND
HEART FAILURE
NEBIVOLOL LOBIVON
CHRONIC STABLE ANGINA RANOLAZINE RANEXA
GOUTY ARTHRITIS FEBUXOSTAT ADENURIC
MIGRAINS FROVATRIPTAN MIGRALIN
HERPES ZOSTER BRIVUDIN BRIVIR
IRRITABLE BOWEL SYNDROME OTILONIUM  BROMIDE DORALIN
HYPERLIPIDEMIA PRAVASTATIN MAXUDIN
INFECTIONS MIDECAMYCIN MIOCAMEN

 

Διεύθυνση:
7, A. Damvergi, 10445 – Athens, Greece

Telephone:
+30 (210) 8316 111

Fax:
+30 (210) 8317 343